Investors are valuing Elon Musk's Neuralink at $42 billion on secondary markets (www.businessinsider.com)

Elon Musk's brain chip startup, Neuralink, is seeing its valuation skyrocketing to as much as $42 billion in recent secondary market transactions, a substantial increase from the $9 billion valuation it held during its last funding round. This surge reflects heightened investor interest in Musk's ventures, particularly after SpaceX's recent IPO. Transactions have varied between $29 billion and $42 billion, with bids reportedly reaching nearly $60 billion as private investors scramble for a stake in Musk's AI and robotics initiatives. Neuralink's technology focuses on developing brain implants aimed at enabling people with paralysis to control computers with their thoughts and potentially restoring vision. Currently, the company has implanted chips in 21 trial patients. Despite the enthusiasm and high valuations in the secondary market driven by demand, opinions among investors vary, with some concerned about the sustainability of such pricing. As Neuralink demonstrates significant technological promise, its trajectory may influence future funding and development in the AI and neurotechnology sectors.